Summary & Overview
HCPCS G8928: Adjuvant Chemotherapy Not Prescribed or Previously Received
HCPCS Level II code G8928 denotes that adjuvant chemotherapy was not prescribed or previously received for documented reasons in a patient with cancer. This code captures both clinical contraindications (for example, comorbid illness, metastasis, allergy, poor performance status) and non-clinical or administrative reasons (patient refusal, recent diagnosis within reporting windows, enrollment in clinical trials, or other system issues). Nationally, G8928 matters because it supports standardized reporting of guideline-concordant care and exceptions to expected chemotherapy use, informing quality measurement, case review, and payer adjudication.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will learn the clinical context and intended use of the code, typical sites of service where it is recorded, and what to expect in documentation and reporting workflows. The publication outlines benchmarks and common reporting considerations, highlights relevant policy and quality-reporting implications, and summarizes the operational contexts in which the code is applied. Data not available in the input for specific modifiers, associated taxonomies, ICD-10 crosswalks, related codes, or service-line cost details are noted as unavailable.
Billing Code Overview
HCPCS Level II code G8928 documents cases where adjuvant chemotherapy was not prescribed or previously received for documented reasons. The description lists clinical and non-clinical reasons that justify omission, including medical comorbidities, metastasis, allergy or contraindication, poor performance status, patient refusal, enrollment in a clinical trial that precludes chemotherapy, timing relative to the reporting period, and other system or patient reasons.
-
Service type: Quality reporting/clinical omission indicator reflecting chemotherapy management decisions following a cancer diagnosis
-
Typical site of service: Oncology clinics, hospital outpatient departments, and other settings where chemotherapy decision-making and cancer care quality reporting occur
Clinical & Coding Specifications
Clinical Context
A typical patient is a woman with a recent history of early-stage breast cancer who presents for an oncology follow-up visit during which the multidisciplinary team documents that adjuvant chemotherapy is not prescribed or previously received for documented reasons. Example scenario: a 72-year-old woman with hormone receptor–positive, node-negative breast cancer diagnosed seven years prior, now seen in medical oncology to discuss systemic therapy; due to advanced age, multiple cardiac comorbidities (ischemic cardiomyopathy, EF 35%), poor performance status (ECOG 3), and patient refusal after informed discussion, the oncology team documents that adjuvant chemotherapy will not be prescribed. The clinician records the specific reason(s) in the chart (medical contraindication, poor performance status, patient refusal) and assigns billing code G8928 for reporting.
Clinical workflow:
-
Referral or routine oncology follow-up visit is scheduled.
-
Clinician reviews oncologic history, pathology, and current staging; evaluates comorbidities and functional status.
-
Shared decision-making discussion occurs, documenting contraindications (e.g., cardiac disease), time-since-diagnosis considerations, enrollment in clinical trials, or explicit patient refusal.
-
Documentation specifies the precise reason(s) for not prescribing adjuvant chemotherapy, with date and clinician signature.
-
Billing staff applies HCPCS Level II code
G8928on the claim to indicate adjuvant chemotherapy was not prescribed or previously received for documented reasons.